Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Junko Asano
Targeting BCL2 With Venetoclax Is a Promising Therapeutic Strategy for "Double-Protein-Expression" Lymphoma With MYC and BCL2 Rearrangements
Haematologica
Hematology
Related publications
Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma
Cancer Discovery
Oncology
Sequence Based Analysis of U-2973, a Cell Line Established From a Double-Hit B-Cell Lymphoma With Concurrent MYC and BCL2 Rearrangements
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Cryptic Myc and Bcl2 Rearrangements Are Among a Range of Genetic Mechanisms Underlying the Double Hit Signature in Non-Double Hit Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Detailed Molecular Analysis and Evaluation of Prognosis in Cases With High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
British Journal of Haematology
Hematology
Characterization of a Novel Venetoclax Resistance Mutation (BCL2 Phe104Ile) Observed in Follicular Lymphoma
British Journal of Haematology
Hematology
MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
PLoS ONE
Multidisciplinary
P53 Expression Correlates With Poorer Survival and Augments the Negative Prognostic Effect of MYC Rearrangement, Expression or Concurrent MYC/BCL2 Expression in Diffuse Large B-Cell Lymphoma
Modern Pathology
Forensic Medicine
Pathology
C-Myc and BCL2: Correlation Between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma
Asian Pacific Journal of Cancer Prevention
